Novel mutation of COG5 in a Taiwanese girl with congenital disorders of glycosylation manifesting as developmental delay
- PMID: 38559322
- PMCID: PMC10981151
- DOI: 10.1016/j.ymgmr.2024.101072
Novel mutation of COG5 in a Taiwanese girl with congenital disorders of glycosylation manifesting as developmental delay
Abstract
We are documenting the case of An 11-year-old girl who has been followed up at our out-patient clinic since birth with clinical presentations including intrauterine growth restriction, recurrent periodic fever in infancy, hypotonia, global developmental delay, liver function impairment with cirrhotic changes, and clinodactyly. Congenital abnormalities were suspected but a series of examinations including brain MRI, liver biopsy and muscle biopsy yielded insignificant findings. Whole genome sequencing (WGS) was conducted and revealed three novel mutations (c2T > G, c1826T > C, c.556-560delAGTAAinsCT) of the COG5 gene. A diagnosis of COG5-congenital disorders of glycosylation (COG5-CDG, or CDG IIi), with neurologic presentation was established. Sanger sequencing in the patient and her parents confirmed the compound heterozygous mutation. Upon literature review, we identified the patient as the first case of COG5-CDG in Taiwan. Our study enhances the clarity of the correlation between the mutative genes and the presentation of COG5-CDG.
Keywords: COG5; Congenital disorders of glycosylation; Developmental delay.
© 2024 The Authors. Published by Elsevier Inc.
Conflict of interest statement
There are no conflicts of interest to disclose.
Figures



Similar articles
-
Identification of Two Novel Mutations in COG5 Causing Congenital Disorder of Glycosylation.Front Genet. 2020 Feb 27;11:168. doi: 10.3389/fgene.2020.00168. eCollection 2020. Front Genet. 2020. PMID: 32174980 Free PMC article.
-
Characterization of a missense variant in COG5 in a Tunisian patient with COG5-CDG syndrome and insights into the effect of non-synonymous variants on COG5 protein.J Hum Genet. 2024 Nov;69(11):591-597. doi: 10.1038/s10038-024-01273-2. Epub 2024 Jul 11. J Hum Genet. 2024. PMID: 38987656
-
MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.J Mass Spectrom. 2017 Jun;52(6):372-377. doi: 10.1002/jms.3936. J Mass Spectrom. 2017. PMID: 28444691
-
Congenital disorders of glycosylation with emphasis on cerebellar involvement.Semin Neurol. 2014 Jul;34(3):357-66. doi: 10.1055/s-0034-1387197. Epub 2014 Sep 5. Semin Neurol. 2014. PMID: 25192513 Review.
-
ALG11-CDG: novel variant and review of the literature.J Pediatr Endocrinol Metab. 2023 Feb 28;36(4):409-413. doi: 10.1515/jpem-2022-0480. Print 2023 Apr 25. J Pediatr Endocrinol Metab. 2023. PMID: 36843332 Review.
References
-
- Paesold-Burda P., Maag C., Troxler H., Foulquier F., Kleinert P., Schnabel S., Baumgartner M., Hennet T. Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation. Hum. Mol. Genet. 2009;18:4350–4356. - PubMed
-
- Schjoldager K.T., Narimatsu Y., Joshi H.J., Clausen H. Global view of human protein glycosylation pathways and functions. Nat. Rev. Mol. Cell Biol. 2020;21:729–749. - PubMed
-
- Kyriakie Sarafoglou G.F.H., Roth Karl S. McGraw Hill / Medical; 2017. Pediatric Endocrinology and Inborn Errors of Metabolism, 2e.
LinkOut - more resources
Full Text Sources